PHAXIAM Therapeutics S.A.
Financial ratios & Valuation

Forward Multiples (2025 – 2026)

20252026
Price/Earnings ratio
N/AN/A
Price/Sales ratio
N/AN/A
Earnings per Share (EPS)
$-1.21N/A

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-133.68-104.12-84.41-96.45-27.71-18.82-18.94-9.10-421.09N/AN/A-23.27
Price/Sales ratio
271.11145.0693.80N/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
33.0633.1651.9017.827.2713.7852.3221.434.06N/AN/A10.53
Price/Cash Flow ratio
-163.63-107.23-105.02-130.92-26.98-27.23-26.84-8.62-3.00N/AN/A-27.10
Price/Free Cash Flow ratio
-154.62-105.28-95.52-122.54-19.80-18.59-26.26-8.57-3.00N/AN/A-19.20
Price/Earnings Growth ratio
1.46-2.41-3.143.03-1.99-0.29-1.320.214.22N/AN/A-1.14
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-204.81%-144.60%-113.54%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
-203.25%-139.34%-111.07%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
-202.79%-139.31%-111.12%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
0.22%0.02%-0.04%0.00%-0.00%0.00%-0.00%-0.00%177.81%N/AN/A-0.00%
Return on Assets
-21.81%-28.32%-48.73%-17.17%-22.77%-52.85%-91.16%-80.57%-0.49%N/AN/A-37.81%
Return On Equity
-24.73%-31.85%-61.48%-18.48%-26.25%-73.23%-276.19%-235.48%-0.96%N/AN/A-49.74%
Return on Capital Employed
-24.61%-32.88%-57.97%-16.81%-29.63%-64.94%-134.81%-120.85%-8.19%N/AN/A-47.28%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Quick Ratio
9.239.206.6716.497.194.081.692.003.54N/AN/A5.63
Cash ratio
8.688.115.9315.986.503.681.511.683.32N/AN/A5.09
Days of Sales Outstanding
177.35200.1881.48N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
16.575.622.682.5215.222.50-0.05-0.47159.15N/AN/A8.86
Operating Cycle
193.92205.8084.16N/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
174.15124.3789.44115.76181.6335.4829.83168.68196.05N/AN/A108.56
Cash Conversion Cycle
19.7781.42-5.27N/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.010.010.060.010.010.110.340.380.29N/AN/A0.06
Debt Equity Ratio
0.020.010.080.010.010.161.031.110.57N/AN/A0.08
Long-term Debt to Capitalization
0.010.000.070.010.000.120.470.500.30N/AN/A0.06
Total Debt to Capitalization
0.020.010.070.010.010.140.500.520.36N/AN/A0.07
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
-9.40-20.59-6.14-8.68-19.44-3.06-1.88-2.23-2.34N/AN/A-11.25
Company Equity Multiplier
1.131.121.261.071.151.383.022.921.95N/AN/A1.26
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-1.65-1.35-0.89N/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1.051.011.091.061.361.461.021.001.001.00N/A1.41
Cash Flow Coverage Ratio
-9.40-20.59-6.14-8.68-19.44-3.06-1.88-2.23-2.34N/AN/A-11.25
Short Term Coverage Ratio
-21.70-26.17-352.28-29.94-50.54-28.4-13.35-28.65-9.51N/AN/A-39.47
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A